Skip to main content

Table 2 Association between CIP2A expression in patients with acute myeloid leukemia and demographic characteristics, clinical and laboratory data, and risk stratification

From: Prognostic value of CIP2A gene expression in adult Egyptian acute myeloid leukemia patients

Parameter

CIP2A expression

P value

 

High (n = 21)

Low (n = 39)

 
 

Value (mean ± SD) or distribution

(n (%))

Value (mean ± SD) or distribution

(n (%))

 

Age (years)

33.8 ± 2.7

38.5 ± 2.0

0.17

Gender

0.83

 Male

9 (33.3)

18 (66.7)

 

 Female

12 (36.3)

21 (63.7)

 

Hepatomegaly

7 (28.0)

18 (72.0)

0.28

Splenomegaly

5 (21.7)

18 (78.2)

0.11

Lymphadenopathy

1 (8.3)

11 (91.6)

0.04

Total leukocyte count (× 109/L)

41.6 ± 10.6

54.3 ± 10.2

0.43

Hemoglobin (g/dL)

8.2 ± 0.4

8.0 ± 0.3

0.81

Platelets (× 109/L)

45.5 ± 9.6

62.8 ± 14.3

0.41

Peripheral-blood blasts

45.8 ± 5.6

47.9 ± 4.5

0.78

Bone-marrow blasts

58.7 ± 4.3

61.7 ± 3.6

0.61

FLT3

0.38

 Wild type

19 (90.5)

32 (82.1)

 

 Mutant

2 (9.5)

7 (17.9)

 

Risk stratification

0.94

 Favorable

5 (23.8)

9 (23.1)

 

 Intermediate

3 (14.3)

8 (20.5)

 

 Poor

5 (23.8)

9 (23.1)

 

 Not performed

8 (38.1)

13 (33.3)